BACKGROUND: Molecular biological techniques allow the identification of more pathogens associated with community-acquired pneumonia (CAP). AIM: To compare clinical and laboratory parameters of patients with CAP caused by different groups of pathogens. MATERIAL AND METHODS: In a prospective study, immunocompetent adult patients hospitalized with CAP were tested for the presence of a broad range of possible respiratory pathogens using bacterial cultures, polymerase chain reaction, urinary antigen testing and serology. RESULTS: Pathogens were detected in 367 of 935 patients with CAP (39.2%). Streptococcus pneumoniae (10.7%) and influenza virus (6%) were the most frequently identified bacterial and viral pathogens, respectively. Pneumococcal pneumonia predominated in older adults, with multiple comorbidities, with elevation of inflammatory parameters and hypoxemia, like other bacterial pneumonias. Viral pneumonia predominated in elderly patients with multiple comorbidities, with a shorter hospital length of stay and lower mortality. Pneumonia associated with atypical microorganisms predominated in young adults, smokers, with subacute clinical evolution. Their hospital stays and lethality was similar to other bacterial pneumonias. Viral and classical bacterial pneumonias predominated in high risk pneumonia severity index categories. Although several variables were associated with the detection of a pathogen group, substantial overlap avoided the identification of reliable clinical predictors to distinguish etiologies. CONCLUSIONS: The clinical and radiographic characteristics were similar in pulmonary infections caused by classical bacteria, respiratory viruses and atypical microorganisms. Therefore, microbial testing for common respiratory pathogens is still necessary to optimize treatment.
BACKGROUND: Molecular biological techniques allow the identification of more pathogens associated with community-acquired pneumonia (CAP). AIM: To compare clinical and laboratory parameters of patients with CAP caused by different groups of pathogens. MATERIAL AND METHODS: In a prospective study, immunocompetent adult patients hospitalized with CAP were tested for the presence of a broad range of possible respiratory pathogens using bacterial cultures, polymerase chain reaction, urinary antigen testing and serology. RESULTS: Pathogens were detected in 367 of 935 patients with CAP (39.2%). Streptococcus pneumoniae (10.7%) and influenza virus (6%) were the most frequently identified bacterial and viral pathogens, respectively. Pneumococcal pneumonia predominated in older adults, with multiple comorbidities, with elevation of inflammatory parameters and hypoxemia, like other bacterial pneumonias. Viral pneumonia predominated in elderly patients with multiple comorbidities, with a shorter hospital length of stay and lower mortality. Pneumonia associated with atypical microorganisms predominated in young adults, smokers, with subacute clinical evolution. Their hospital stays and lethality was similar to other bacterial pneumonias. Viral and classical bacterial pneumonias predominated in high risk pneumonia severity index categories. Although several variables were associated with the detection of a pathogen group, substantial overlap avoided the identification of reliable clinical predictors to distinguish etiologies. CONCLUSIONS: The clinical and radiographic characteristics were similar in pulmonary infections caused by classical bacteria, respiratory viruses and atypical microorganisms. Therefore, microbial testing for common respiratory pathogens is still necessary to optimize treatment.
Authors: Ho Yin Chung; Lai Shan Tam; Shirley Chiu Wai Chan; Jason Pui Yin Cheung; Pui Yan Wong; Chu Oi Ciang; Hoi Yan Ng; Mei Yan Law; Tin Lok Lai; Ching Han Wong Journal: Ther Adv Musculoskelet Dis Date: 2020-10-13 Impact factor: 5.346
Authors: Mentor Ali Ber Lucien; Michael F Canarie; Paul E Kilgore; Gladzdin Jean-Denis; Natael Fénélon; Manise Pierre; Mauricio Cerpa; Gerard A Joseph; Gina Maki; Marcus J Zervos; Patrick Dely; Jacques Boncy; Hatim Sati; Ana Del Rio; Pilar Ramon-Pardo Journal: Int J Infect Dis Date: 2021-01-09 Impact factor: 3.623
Authors: Rut Del Valle; Álvaro Ballesteros; Cristina Calvo; Talía Sainz; Ana Mendez; Carlos Grasa; Paula R Molina; María J Mellado; Francisco J Sanz-Santaeufemia; Blanca Herrero; Lourdes Calleja; Antoni Soriano-Arandes; Susana Melendo; Elena Rincón-López; Alicia Hernánz; Cristina Epalza; Carmen García-Baeza; E Rupérez-García; Arantxa Berzosa; Angustias Ocaña; Alvaro Villarroya-Villalba; Ana Barrios; Enrique Otheo; Juan C Galán; Mario José Rodríguez; Juan M Mesa; Sara Domínguez-Rodríguez; Cinta Moraleda; Alfredo Tagarro Journal: Pediatr Pulmonol Date: 2022-07-08
Authors: María Heredia-Rodríguez; Sara Balbás-Álvarez; Mario Lorenzo-López; Estefanía Gómez-Pequera; Pablo Jorge-Monjas; Silvia Rojo-Rello; Laura Sánchez-De Prada; Ivan Sanz-Muñoz; José María Eiros; Pedro Martínez-Paz; Hugo Gonzalo-Benito; Álvaro Tamayo-Velasco; Marta Martín-Fernández; Pilar Sánchez-Conde; Eduardo Tamayo; Esther Gómez-Sánchez Journal: Medicine (Baltimore) Date: 2022-08-12 Impact factor: 1.817